John Brassil (Kerry, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

461. To ask the Minister for Health the expenditure incurred in the GMS scheme on generic drugs, branded generics and proprietary drugs with an equivalent generic and on proprietary drugs without an equivalent generic in each of the years 2015 to 2018, in tabular form. [37705/19]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

John Brassil (Kerry, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

462. To ask the Minister for Health the expenditure incurred in the DPS scheme on generic drugs, branded generics and proprietary drugs with an equivalent generic and on proprietary drugs without an equivalent generic in each of the years 2015 to 2018, in tabular form. [37706/19]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

John Brassil (Kerry, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

463. To ask the Minister for Health the expenditure incurred in the LTI scheme on generic drugs, branded generics and proprietary drugs with an equivalent generic and on proprietary drugs without an equivalent generic in each of the years 2015 to 2018, in tabular form. [37707/19]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.